Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in INKT — MiNK Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to INKT Full portfolio

Position in INKT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$105
+$11 QoQ
Shares Held
9
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 27 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. INKT ranks #392 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in INKT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $105 9
2026-03-31 $94 9
2025-12-31 $100 9
2025-09-30 $126 9
2025-06-30 $88 12
2025-03-31 $258 30
2024-12-31 $225 325
2024-09-30 $96 129
2024-06-30 $101 107
2024-03-31 $97 107
2023-12-31 $114 107
2023-09-30 $117 107
2023-06-30 $224 107
2022-06-30 $348 247
2022-03-31 $2,117 941